Impact of Ca/P disorders on risks and comorbidities

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Clinical Biochemistry

Background:

• Chronic kidney disease (CKD) is associated with significantly higher rates of cardiovascular morbidity and mortality.
• Mineral metabolism (MM) derangements, particularly involving calcium (Ca) and phosphate (P), are suspected contributors to poor outcomes in CKD patients.
• These derangements are hypothesized to negatively impact vascular calcification, a process linked to cardiovascular events.

Purpose of the Study:

• To critically evaluate the evidence linking mineral metabolism changes to increased mortality in CKD patients.
• To assess whether correcting mineral metabolism parameters improves clinical outcomes in CKD.
• To determine if a causal relationship exists between MM derangements and CKD mortality.

Main Methods:

• Review of existing experimental in vitro studies and retrospective association studies.
• Analysis of the temporal relationship between mineral metabolism changes and mortality rates in CKD progression.
• Examination of clinical data regarding the effects of MM parameter correction on patient outcomes.

Main Results:

• Current evidence supporting a causal link between MM changes and CKD mortality is primarily based on in vitro or retrospective studies, lacking definitive cause-effect demonstration.
• Calcium and phosphate abnormalities often appear in later stages of CKD, contrasting with the early onset of increased mortality.
• No robust clinical evidence demonstrates that correcting MM parameters leads to improved clinical outcomes in CKD patients.

Conclusions:

• While experimental and retrospective data suggest a role for Ca and P derangements in CKD mortality, convincing clinical data is lacking.
• There is insufficient evidence to conclude that correcting mineral metabolism parameters improves the clinical outcome of CKD patients.
• Further well-designed clinical trials are needed to establish a causal link and therapeutic benefit of MM correction in CKD.